{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:44:44Z","timestamp":1780393484012,"version":"3.54.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["JO-886\/1-3"],"award-info":[{"award-number":["JO-886\/1-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008436","name":"Ernst und Berta Grimmke Stiftung","doi-asserted-by":"crossref","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/501100008436","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Verein Gl\u00fcck im Blick","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Glaucoma is characterized by a progressive damage of the retina and the optic nerve. Despite a huge research interest, the exact pathomechanisms are still unknown. In the experimental autoimmune glaucoma model, rats develop glaucoma-like damage of the retina and the optic nerve after immunization with an optic nerve antigen homogenate (ONA). An early activation of the complement system, even before optic nerve degeneration, was reported in this model. Here, we investigated the effects of a monoclonal antibody against complement factor C5 on optic nerves. Rats were immunized with ONA and compared to controls. In one eye of some ONA animals, the antibody against C5 was intravitreally injected (15\u00a0\u03bcmol: ONA + C5-I or 25\u00a0\u03bcmol: ONA + C5-II) before immunization and then every 2\u00a0weeks. After 6\u00a0weeks, optic nerves were processed for histology (<jats:italic>n<\/jats:italic>\u2009=\u20096\/group). These analyses demonstrated that the intravitreal therapy reduced the depositions of the membrane attack complex compared to ONA animals (ONA + C5-I: <jats:italic>p<\/jats:italic>\u2009=\u20090.005; ONA + C5-II: <jats:italic>p<\/jats:italic>\u2009=\u20090.002). Cellular infiltration was significantly reduced in the ONA + C5-I group (<jats:italic>p<\/jats:italic>\u2009=\u20090.003), but not in ONA + C5-II tissues (<jats:italic>p<\/jats:italic>\u2009=\u20090.41). Furthermore, SMI-32 staining revealed that neurofilament was preserved in both treatment groups compared to ONA optic nerves (both <jats:italic>p<\/jats:italic>\u2009=\u20090.002). A decreased amount of microglia was found in treated animals in comparison to the ONA group (ONA + C5-I: <jats:italic>p<\/jats:italic>\u2009=\u20090.03; ONA + C5-II: <jats:italic>p<\/jats:italic>\u2009=\u20090.009). We observed, for the first time, that a complement system inhibition could prevent optic nerve damage in an autoimmune glaucoma model. Therefore, complement inhibition could serve as a\u00a0new therapeutic tool for glaucoma.<\/jats:p>","DOI":"10.1007\/s00441-020-03240-7","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T09:25:07Z","timestamp":1594977907000},"page":"293-306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Preservation of optic nerve structure by complement inhibition in experimental glaucoma"],"prefix":"10.1007","volume":"382","author":[{"given":"Caroline J.","family":"Gassel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Reinehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Burkhard","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-0829","authenticated-orcid":false,"given":"Stephanie C.","family":"Joachim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"3240_CR1","doi-asserted-by":"crossref","unstructured":"Bayly-Jones C, Bubeck D, Dunstone MA (2017) The mystery behind membrane insertion: a review of the complement membrane attack complex. Philos Trans R Soc Lond Ser B Biol Sci 372","DOI":"10.1098\/rstb.2016.0221"},{"key":"3240_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00347-014-3100-6","volume":"112","author":"S Becker","year":"2015","unstructured":"Becker S, Reinehr S, Dick HB, Joachim SC (2015) Complement activation after induction of ocular hypertension in an animal model. Ophthalmologe 112:41\u201348","journal-title":"Ophthalmologe"},{"key":"3240_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbi.2011.07.241","volume":"26","author":"N Boehm","year":"2012","unstructured":"Boehm N, Wolters D, Thiel U, Lossbrand U, Wiegel N, Pfeiffer N, Grus FH (2012) New insights into autoantibody profiles from immune privileged sites in the eye: a glaucoma study. Brain Behav Immun 26:96\u2013102","journal-title":"Brain Behav Immun"},{"key":"3240_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0161-6420(98)92665-3","volume":"105","author":"L Bonomi","year":"1998","unstructured":"Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S, Varotto A, Tenna V (1998) Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study Ophthalmology 105:209\u2013215","journal-title":"The Egna-Neumarkt Study Ophthalmology"},{"key":"3240_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1167\/iovs.07-1337","volume":"49","author":"A Bosco","year":"2008","unstructured":"Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML (2008) Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA\/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 49:1437\u20131446","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/cne.22516","volume":"519","author":"A Bosco","year":"2011","unstructured":"Bosco A, Steele MR, Vetter ML (2011) Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 519:599\u2013620","journal-title":"J Comp Neurol"},{"key":"3240_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043602","volume":"7","author":"A Bosco","year":"2012","unstructured":"Bosco A, Crish SD, Steele MR, Romero CO, Inman DM, Horner PJ, Calkins DJ, Vetter ML (2012) Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLoS One 7:e43602","journal-title":"PLoS One"},{"key":"3240_CR8","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.ymthe.2018.08.017","volume":"26","author":"A Bosco","year":"2018","unstructured":"Bosco A, Anderson SR, Breen KT, Romero CO, Steele MR, Chiodo VA, Boye SL, Hauswirth WW, Tomlinson S, Vetter ML (2018) Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma. Molecular therapy : the journal of the American Society of Gene Therapy 26:2379\u20132396","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"key":"3240_CR9","unstructured":"Bowling B (2016) Kanski's clinical ophthalmology"},{"key":"3240_CR10","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1167\/iovs.15-18999R2","volume":"57","author":"C Casola","year":"2016","unstructured":"Casola C, Reinehr S, Kuehn S, Stute G, Spiess BM, Dick HB, Joachim SC (2016) Specific inner retinal layer cell damage in an autoimmune glaucoma model is induced by GDNF with or without HSP27. Invest Ophthalmol Vis Sci 57:3626\u20133639","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.survophthal.2013.09.003","volume":"59","author":"HK Cho","year":"2014","unstructured":"Cho HK, Kee C (2014) Population-based glaucoma prevalence studies in Asians. Surv Ophthalmol 59:434\u2013447","journal-title":"Surv Ophthalmol"},{"key":"3240_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2249.2009.04070.x","volume":"159","author":"DA Copland","year":"2010","unstructured":"Copland DA, Hussain K, Baalasubramanian S, Hughes TR, Morgan BP, Xu H, Dick AD, Nicholson LB (2010) Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol 159:303\u2013314","journal-title":"Clin Exp Immunol"},{"key":"3240_CR13","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.4049\/jimmunol.125.5.2055","volume":"125","author":"C DeLisi","year":"1980","unstructured":"DeLisi C, Boyle M, Borsos T (1980) Analysis of the colloid osmotic step of complement-mediated immune hemolysis. J Immunol 125:2055\u20132062","journal-title":"J Immunol"},{"key":"3240_CR14","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/S0161-6420(94)31090-6","volume":"101","author":"I Dielemans","year":"1994","unstructured":"Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT (1994) The prevalence of primary open-angle glaucoma in a population-based study in the Netherlands. The Rotterdam Study Ophthalmology 101:1851\u20131855","journal-title":"The Rotterdam Study Ophthalmology"},{"key":"3240_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/archopht.1996.01100130295012","volume":"114","author":"EB Dreyer","year":"1996","unstructured":"Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA (1996) Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114:299\u2013305","journal-title":"Arch Ophthalmol"},{"key":"3240_CR16","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1167\/iovs.10-5284","volume":"51","author":"A Ebneter","year":"2010","unstructured":"Ebneter A, Casson RJ, Wood JP, Chidlow G (2010) Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci 51:6448\u20136460","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.002","volume":"101","author":"EGS","year":"2017","unstructured":"EGS (2017) European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th edition\u2014chapter 2: classification and terminology. Br J Ophthalmol 101:73\u2013127","journal-title":"Br J Ophthalmol"},{"key":"3240_CR18","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, RRA B, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR, Vision Loss Expert Group of the Global Burden of Disease S (2017) Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health 5:e1221\u2013e1234","journal-title":"Lancet Glob Health"},{"key":"3240_CR19","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","volume":"183","author":"MI Fonseca","year":"2009","unstructured":"Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD, LaFerla FM, Taylor SM, Woodruff TM, Tenner AJ (2009) Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J Immunol 183:1375\u20131383","journal-title":"J Immunol"},{"key":"3240_CR20","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00417-011-1633-9","volume":"249","author":"OW Gramlich","year":"2011","unstructured":"Gramlich OW, Joachim SC, Gottschling PF, Laspas P, Cuny CS, Pfeiffer N, Grus FH (2011) Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis. Graefes Arch Clin Exp Ophthalmol 249:1009\u20131020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3240_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057557","volume":"8","author":"OW Gramlich","year":"2013","unstructured":"Gramlich OW, Beck S, von Thun Und Hohenstein-Blaul N, Boehm N, Ziegler A, Vetter JM, Pfeiffer N, Grus FH (2013) Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina. PLoS One 8:e57557","journal-title":"PLoS One"},{"key":"3240_CR22","doi-asserted-by":"crossref","unstructured":"Grotegut P, Kuehn S, Meissner W, Dick HB, Joachim SC (2019) Intravitreal S100B injection triggers a time-dependent microglia response in a pro-inflammatory manner in retina and optic nerve. Mol Neurobiol","DOI":"10.1007\/s12035-019-01786-4"},{"key":"3240_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/IJG.0b013e318156a592","volume":"17","author":"FH Grus","year":"2008","unstructured":"Grus FH, Joachim SC, Wuenschig D, Rieck J, Pfeiffer N (2008) Autoimmunity and glaucoma. J Glaucoma 17:79\u201384","journal-title":"J Glaucoma"},{"key":"3240_CR24","first-page":"668","volume":"93","author":"D Gupta","year":"2016","unstructured":"Gupta D, Chen PP (2016) Glaucoma. Am Fam Physician 93:668\u2013674","journal-title":"Am Fam Physician"},{"key":"3240_CR25","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1167\/iovs.06-0051","volume":"47","author":"M He","year":"2006","unstructured":"He M, Foster PJ, Ge J, Huang W, Zheng Y, Friedman DS, Lee PS, Khaw PT (2006) Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou. Invest Ophthalmol Vis Sci 47:2782\u20132788","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2017.04.007","volume":"309","author":"DAE Hendrickx","year":"2017","unstructured":"Hendrickx DAE, van Eden CG, Schuurman KG, Hamann J, Huitinga I (2017) Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J Neuroimmunol 309:12\u201322","journal-title":"J Neuroimmunol"},{"key":"3240_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-017-0210-z","volume":"12","author":"MX Hernandez","year":"2017","unstructured":"Hernandez MX, Jiang S, Cole TA, Chu SH, Fonseca MI, Fang MJ, Hohsfield LA, Torres MD, Green KN, Wetsel RA, Mortazavi A, Tenner AJ (2017) Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss. Mol Neurodegener 12:66","journal-title":"Mol Neurodegener"},{"key":"3240_CR28","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1523\/JNEUROSCI.0584-17.2017","volume":"37","author":"AM Hilla","year":"2017","unstructured":"Hilla AM, Diekmann H, Fischer D (2017) Microglia are irrelevant for neuronal degeneration and axon regeneration after acute injury. J Neurosci 37:6113\u20136124","journal-title":"J Neurosci"},{"key":"3240_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-2094-10-76","volume":"10","author":"GR Howell","year":"2013","unstructured":"Howell GR, Soto I, Ryan M, Graham LC, Smith RS, John SW (2013) Deficiency of complement component 5 ameliorates glaucoma in DBA\/2J mice. J Neuroinflammation 10:76","journal-title":"J Neuroinflammation"},{"key":"3240_CR30","doi-asserted-by":"crossref","unstructured":"Inman DM, Lambert WS, Calkins DJ, Horner PJ (2013) Alpha-lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction. PLoS One 8:e65389","DOI":"10.1371\/journal.pone.0065389"},{"key":"3240_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","volume":"57","author":"D Ito","year":"1998","unstructured":"Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S (1998) Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 57:1\u20139","journal-title":"Brain Res Mol Brain Res"},{"key":"3240_CR32","first-page":"1641","volume":"111","author":"A Iwase","year":"2004","unstructured":"Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, Inoue Y, Kitazawa Y, Tajimi Study Group JGS (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi study. Ophthalmology 111:1641\u20131648","journal-title":"Ophthalmology"},{"key":"3240_CR33","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.molimm.2011.07.012","volume":"48","author":"P Jha","year":"2011","unstructured":"Jha P, Banda H, Tytarenko R, Bora PS, Bora NS (2011) Complement mediated apoptosis leads to the loss of retinal ganglion cells in animal model of glaucoma. Mol Immunol 48:2151\u20132158","journal-title":"Mol Immunol"},{"key":"3240_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/02713680701375183","volume":"32","author":"SC Joachim","year":"2007","unstructured":"Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH (2007) Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr Eye Res 32:501\u2013509","journal-title":"Curr Eye Res"},{"key":"3240_CR35","first-page":"1804","volume":"19","author":"SC Joachim","year":"2013","unstructured":"Joachim SC, Reinehr S, Kuehn S, Laspas P, Gramlich OW, Kuehn M, Tischoff I, von Pein HD, Dick HB, Grus FH (2013) Immune response against ocular tissues after immunization with optic nerve antigens in a model of autoimmune glaucoma. Mol Vis 19:1804\u20131814","journal-title":"Mol Vis"},{"key":"3240_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/IJG.0b013e31818c6ef6","volume":"18","author":"EC Johnson","year":"2009","unstructured":"Johnson EC, Morrison JC (2009) Friend or foe? Resolving the impact of glial responses in glaucoma. J Glaucoma 18:341\u2013353","journal-title":"J Glaucoma"},{"key":"3240_CR37","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.ophtha.2010.10.016","volume":"118","author":"CS Kim","year":"2011","unstructured":"Kim CS, Seong GJ, Lee NH, Song KC, Namil Study Group KGS (2011) Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology 118:1024\u20131030","journal-title":"Ophthalmology"},{"key":"3240_CR38","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0161-6420(92)31774-9","volume":"99","author":"BE Klein","year":"1992","unstructured":"Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, Menage MJ (1992) Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 99:1499\u20131504","journal-title":"Ophthalmology"},{"key":"3240_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.freeradbiomed.2005.03.025","volume":"39","author":"ML Ko","year":"2005","unstructured":"Ko ML, Peng PH, Ma MC, Ritch R, Chen CF (2005) Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med 39:365\u2013373","journal-title":"Free Radic Biol Med"},{"key":"3240_CR40","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.exer.2006.03.002","volume":"83","author":"MH Kuehn","year":"2006","unstructured":"Kuehn MH, Kim CY, Ostojic J, Bellin M, Alward WL, Stone EM, Sakaguchi DS, Grozdanic SD, Kwon YH (2006) Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp Eye Res 83:620\u2013628","journal-title":"Exp Eye Res"},{"key":"3240_CR41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fncel.2018.00312","volume":"12","author":"S Kuehn","year":"2018","unstructured":"Kuehn S, Meissner W, Grotegut P, Theiss C, Dick HB, Joachim SC (2018) Intravitreal S100B injection leads to progressive glaucoma like damage in retina and optic nerve. Front Cell Neurosci 12:312","journal-title":"Front Cell Neurosci"},{"key":"3240_CR42","first-page":"1063","volume":"39","author":"WA Lagreze","year":"1998","unstructured":"Lagreze WA, Knorle R, Bach M, Feuerstein TJ (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39:1063\u20131066","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR43","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.1167\/iovs.10-6889","volume":"52","author":"P Laspas","year":"2011","unstructured":"Laspas P, Gramlich OW, Muller HD, Cuny CS, Gottschling PF, Pfeiffer N, Dick HB, Joachim SC, Grus FH (2011) Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens. Invest Ophthalmol Vis Sci 52:8835\u20138848","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.18240\/ijo.2020.01.24","volume":"13","author":"H Liu","year":"2020","unstructured":"Liu H, Anders F, Funke S, Mercieca K, Grus F, Prokosch V (2020) Proteome alterations in aqueous humour of primary open angle glaucoma patients. Int J Ophthalmol 13:176\u2013179","journal-title":"Int J Ophthalmol"},{"key":"3240_CR45","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1167\/iovs.03-0138","volume":"44","author":"F Mabuchi","year":"2003","unstructured":"Mabuchi F, Aihara M, Mackey MR, Lindsey JD, Weinreb RN (2003) Optic nerve damage in experimental mouse ocular hypertension. Invest Ophthalmol Vis Sci 44:4321\u20134330","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrd4657","volume":"14","author":"BP Morgan","year":"2015","unstructured":"Morgan BP, Harris CL (2015) Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov 14:857\u2013877","journal-title":"Nat Rev Drug Discov"},{"key":"3240_CR47","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12031-015-0707-2","volume":"58","author":"R Noristani","year":"2016","unstructured":"Noristani R, Kuehn S, Stute G, Reinehr S, Stellbogen M, Dick HB, Joachim SC (2016) Retinal and optic nerve damage is associated with early glial responses in an experimental autoimmune Glaucoma model. J Mol Neurosci 58:470\u2013482","journal-title":"J Mol Neurosci"},{"issue":"2835\u20132848","key":"3240_CR48","volume":"29","author":"D Pauly","year":"2019","unstructured":"Pauly D, Agarwal D, Dana N, Schafer N, Biber J, Wunderlich KA, Jabri Y, Straub T, Zhang NR, Gautam AK, Weber BHF, Hauck SM, Kim M, Curcio CA, Stambolian D, Li M, Grosche A (2019) Cell-type-specific complement expression in the healthy and diseased retina. Cell Rep 29(2835\u20132848):e2834","journal-title":"Cell Rep"},{"key":"3240_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fncel.2016.00140","volume":"10","author":"S Reinehr","year":"2016","unstructured":"Reinehr S, Reinhard J, Gandej M, Kuehn S, Noristani R, Faissner A, Burkhard Dick H, Joachim SC (2016) Simultaneous complement response via lectin pathway in retina and optic nerve in an experimental autoimmune Glaucoma model. Front Cell Neurosci 10:140","journal-title":"Front Cell Neurosci"},{"key":"3240_CR50","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1038\/s41598-018-28183-6","volume":"8","author":"S Reinehr","year":"2018","unstructured":"Reinehr S, Reinhard J, Gandej M, Gottschalk I, Stute G, Faissner A, Dick HB, Joachim SC (2018) S100B immunization triggers NF\u03baB and complement activation in an autoimmune glaucoma model. Sci Rep 8:9821","journal-title":"Sci Rep"},{"key":"3240_CR51","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3389\/fphar.2019.01381","volume":"10","author":"S Reinehr","year":"2019","unstructured":"Reinehr S, Gomes SC, Gassel CJ, Asaad MA, Stute G, Schargus M, Dick HB, Joachim SC (2019a) Intravitreal therapy against the complement factor C5 prevents retinal degeneration in an experimental autoimmune Glaucoma model. Front Pharmacol 10:1381","journal-title":"Front Pharmacol"},{"key":"3240_CR52","doi-asserted-by":"crossref","unstructured":"Reinehr S, Reinhard J, Wiemann S, Hesse K, Voss C, Gandej M, Dick HB, Faissner A, Joachim SC (2019b) Transfer of the experimental autoimmune glaucoma model from rats to mice-new options to study Glaucoma disease. Int J Mol Sci 20","DOI":"10.3390\/ijms20102563"},{"key":"3240_CR53","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1007\/s12035-018-1376-2","volume":"56","author":"J Reinhard","year":"2019","unstructured":"Reinhard J, Wiemann S, Joachim SC, Palmhof M, Woestmann J, Denecke B, Wang Y, Downey GP, Faissner A (2019) Heterozygous Meg2 ablation causes intraocular pressure elevation and progressive glaucomatous neurodegeneration. Mol Neurobiol 56:4322\u20134345","journal-title":"Mol Neurobiol"},{"key":"3240_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fncel.2017.00254","volume":"11","author":"M Renner","year":"2017","unstructured":"Renner M, Stute G, Alzureiqi M, Reinhard J, Wiemann S, Schmid H, Faissner A, Dick HB, Joachim SC (2017) Optic nerve degeneration after retinal ischemia\/reperfusion in a rodent model. Front Cell Neurosci 11:254","journal-title":"Front Cell Neurosci"},{"key":"3240_CR55","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0166-2236(97)01139-9","volume":"20","author":"JL Ridet","year":"1997","unstructured":"Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20:570\u2013577","journal-title":"Trends Neurosci"},{"key":"3240_CR56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archopht.120.4.471","volume":"120","author":"AP Rotchford","year":"2002","unstructured":"Rotchford AP, Johnson GJ (2002) Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. Arch Ophthalmol 120:471\u2013478","journal-title":"Arch Ophthalmol"},{"key":"3240_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7\u201335","journal-title":"Acta Neuropathol"},{"key":"3240_CR58","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/glia.20962","volume":"58","author":"JL Son","year":"2010","unstructured":"Son JL, Soto I, Oglesby E, Lopez-Roca T, Pease ME, Quigley HA, Marsh-Armstrong N (2010) Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 58:780\u2013789","journal-title":"Glia"},{"key":"3240_CR59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/00055735-200404000-00003","volume":"15","author":"G Tezel","year":"2004","unstructured":"Tezel G, Wax MB (2004) The immune system and glaucoma. Curr Opin Ophthalmol 15:80\u201384","journal-title":"Curr Opin Ophthalmol"},{"key":"3240_CR60","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1167\/iovs.10-5289","volume":"51","author":"G Tezel","year":"2010","unstructured":"Tezel G, Yang X, Luo C, Kain AD, Powell DW, Kuehn MH, Kaplan HJ (2010) Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci 51:5071\u20135082","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR61","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081\u20132090","journal-title":"Ophthalmology"},{"key":"3240_CR62","first-page":"3615","volume":"41","author":"CK Vorwerk","year":"2000","unstructured":"Vorwerk CK, Naskar R, Schuettauf F, Quinto K, Zurakowski D, Gochenauer G, Robinson MB, Mackler SA, Dreyer EB (2000) Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell death. Invest Ophthalmol Vis Sci 41:3615\u20133621","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR63","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1126\/science.284.5412.339","volume":"284","author":"HG Wang","year":"1999","unstructured":"Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC (1999) Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284:339\u2013343","journal-title":"Science"},{"key":"3240_CR64","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.exer.2010.08.016","volume":"93","author":"MB Wax","year":"2011","unstructured":"Wax MB (2011) The case for autoimmunity in glaucoma. Exp Eye Res 93:187\u2013190","journal-title":"Exp Eye Res"},{"key":"3240_CR65","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.exer.2009.02.005","volume":"88","author":"MB Wax","year":"2009","unstructured":"Wax MB, Tezel G (2009) Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res 88:825\u2013830","journal-title":"Exp Eye Res"},{"key":"3240_CR66","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. Jama 311:1901\u20131911","journal-title":"Jama"},{"key":"3240_CR67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13024-016-0091-6","volume":"11","author":"PA Williams","year":"2016","unstructured":"Williams PA, Tribble JR, Pepper KW, Cross SD, Morgan BP, Morgan JE, John SW, Howell GR (2016) Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. Mol Neurodegener 11:26","journal-title":"Mol Neurodegener"},{"key":"3240_CR68","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1167\/iovs.16-19153","volume":"57","author":"X Yang","year":"2016","unstructured":"Yang X, Hondur G, Tezel G (2016) Antioxidant treatment limits neuroinflammation in experimental glaucoma. Invest Ophthalmol Vis Sci 57:2344\u20132354","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3240_CR69","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1167\/iovs.18-26129","volume":"60","author":"X Yang","year":"2019","unstructured":"Yang X, Zeng Q, Goktas E, Gopal K, Al-Aswad L, Blumberg DM, Cioffi GA, Liebmann JM, Tezel G (2019) T-lymphocyte subset distribution and activity in patients with glaucoma. Invest Ophthalmol Vis Sci 60:877\u2013888","journal-title":"Invest Ophthalmol Vis Sci"}],"updated-by":[{"DOI":"10.1007\/s00441-021-03501-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000}}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-020-03240-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00441-020-03240-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-020-03240-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T21:03:51Z","timestamp":1757106231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00441-020-03240-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["3240"],"URL":"https:\/\/doi.org\/10.1007\/s00441-020-03240-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00441-021-03501-z","asserted-by":"object"}]},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00441-021-03501-z","URL":"https:\/\/doi.org\/10.1007\/s00441-021-03501-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments in this study were approved by the animal care committee of North Rhine-Westphalia, Germany (approval number: 84-02.04.2013.A291) and were carried out in accordance with the ARVO statement for the use of animals in ophthalmic and vision research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}}]}}